FDA Approves EVENITYā„¢ (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture »

| Press Releases, BHOF in the News, Osteoporosis in the News

One in Two Women in the United States Will Suffer a Fracture in Her Lifetime Due to Osteoporosis(1) EVENITY is the First and Only Bone Builder With a Dual Effect That Both Increases Bone Formation and Decreases Bone Loss(2) EVENITY Rapidly Reduces Fracture Risk and Builds New Bone With 12 Months of Therapy(2) THOUSAND OAKS,… Read more »

Protecting Patient Access to Medication (Updated) »

| BHOF in the News, Press Releases

Dear Members of Congress: We want to express our concern regarding any proposal that would repeal the non-interference (NI) clause ā€“ a crucial fixture and protection in the Medicare Part D program. We are concerned that changes to the Part D NI clause could undermine the private negotiations that enable seniors to access affordable prescription… Read more »

Protecting Patient Access to Medication »

| BHOF in the News, Press Releases

Dear Members of Congress: We want to express our concern regarding any proposal that would repeal the non-interference (NI) clause ā€“ a crucial fixture and protection in the Medicare Part D program. We are concerned that changes to the Part D NI clause could undermine the private negotiations that enable seniors to access affordable prescription… Read more »

Did you know that weak bones are not a normal part of aging? »

| Press Releases

The National Osteoporosis Foundation Debunks Myths Surrounding Osteoporosis and the Risk of Fractures While osteoporosis does cause bones to become weak and fragile, so that they break easily ā€“ even from a minor fall or a sneeze ā€“ osteoporosis is not a normal part of aging. Ā It is a disease that is common, serious and… Read more »

NOF Adds to its Mission Department »

| Press Releases

The National Osteoporosis Foundation (NOF), the nationā€™s leading health organization solely dedicated to osteoporosis and bone health, announced the addition of two thoughtful new leaders to its newly designated Mission department, underscoring the organizationā€™s commitment to delivering quality educational programming for patients and healthcare professionals. Samantha Mayberry joins NOF as the Associate Director of Patient… Read more »

NOF Statement On Medicare Open Enrollment »

| Advocacy, BHOF in the News, Press Releases

Patient Group Urges Fix To DXA Screening Reimbursement Rates To Encourage More Osteoporosis Screenings Today, as Medicare Open Enrollment starts, the National Osteoporosis Foundation (NOF) urged policymakers to raise the reimbursement rates for x-ray absorptiometry (DXA) screenings, which are the gold standard for osteoporosis screenings. Currently, bipartisan bills are sitting in both Chambers that would… Read more »

Are You at Risk for Developing Bone Disease? »

| Press Releases

The National Osteoporosis Foundation Joins Organizations Worldwide to Raise Awareness about Osteoporosis and the Risk of Fractures on World Osteoporosis Day, October 20th Did you know that weak bones are not a normal part of aging? Osteoporosis causes bones to become weak and fragile, so that they break easily ā€“ even from a minor fall… Read more »

NOF Named an Official Charity Partner of the TCS New York City Marathon and Fields a Team of Runners Aged 40+ »

| BHOF in the News, Osteoporosis in the News, Press Releases

The National Osteoporosis Foundation (NOF), the leading bone health organization in the U.S., was named an Official Charity Partner of the 2018 TCS New York City Marathon. The race will take place on Sunday, November 4, 2018. For its inaugural team, NOF has secured five women over the age of 40 to join its Be… Read more »

Leading Organizations Meet To Discuss Unmet Needs In Osteoporosis and Outline An Initial Action Plan »

| BHOF in the News, Osteoporosis in the News, Press Releases

June 11, 2018| Press Releases On June 11, 2018, leaders from the National Osteoporosis Foundation (NOF), International Osteoporosis Foundation (IOF), and Amgenā€™s Bone Health and Advocacy RelationsĀ teams convened in London, England at the Royal Academy of Medicine. The purpose of theĀ meeting was to develop a concrete plan for a meaningful collaboration between the twoĀ organizations.Ā Back row:… Read more »